Shares of Acasti Pharma Inc. (CVE:ACST – Get Free Report) passed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of C$0.58 and traded as high as C$0.58. Acasti Pharma shares last traded at C$0.58, with a volume of 2,450 shares.
Acasti Pharma Price Performance
The stock has a 50-day moving average price of C$0.58 and a two-hundred day moving average price of C$0.58. The stock has a market cap of C$18.19 million, a PE ratio of -1.21 and a beta of 1.22.
Acasti Pharma Company Profile
Acasti Pharma Inc, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
See Also
- Five stocks we like better than Acasti Pharma
- Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected
- Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock
- Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement
- Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For
Receive News & Ratings for Acasti Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acasti Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
